Choose Boston Business Journal as a preferred news source to see more of our reporting on Google. The deal could mean over ...

Rising demand for cell-based therapies and technological progress in reprogramming support market expansion. Challenges ...

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

Traditional drug discovery takes 10-15 years and costs billions. Learn how AI is cutting this time to months, creating new ...

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

An announcement from Living Cell Technologies ( ($AU:1AI) ) is now available. Algorae Pharmaceuticals Ltd has launched AlgoraeOS Version 2, a ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

Discover how DAOs revolutionize drug discovery through decentralized funding, transparency, and community governance.

red down pointing triangle to build what the companies say will be the most powerful supercomputer run by a pharmaceutical company to boost the discovery of new medicines. Lilly, which makes the ...

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...